Northeast Medical Research Associates, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Dartmouth MA United States (1955)
Status: No NME R&D (1955)

Organization Overview

First Clinical Trial
2005
NCT00293657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

NE Medical Research Associates, Inc. | Northeast Medical Research, North Dartmouth, MA

Active Ingredients

Drugs in Phase 2 Trials (2)

carbon dioxide (dry ice) (1 trial)

lornoxicam (1 trial)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 2)

Migraine Disorders (Phase 2)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Rhinitis, Allergic, Seasonal (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3